Daiichi Sankyo Company, Limited, commonly referred to as Daiichi Sankyo, is a prominent global pharmaceutical firm headquartered in Tokyo, Japan. Founded in 1899, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative healthcare solutions. Specialising in the research, development, and manufacturing of pharmaceuticals, Daiichi Sankyo is particularly renowned for its contributions to oncology, cardiovascular, and vaccine development. The company’s unique approach combines cutting-edge science with a commitment to improving patient outcomes, positioning it as a leader in the pharmaceutical industry. With a rich history marked by key milestones, Daiichi Sankyo has achieved notable success, including the development of groundbreaking therapies that have transformed treatment paradigms. Its dedication to innovation and quality has solidified its reputation as a trusted name in healthcare worldwide.
How does Daiichi Sankyo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Daiichi Sankyo's score of 82 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Daiichi Sankyo reported total carbon emissions of approximately 4,274,477,000 kg CO2e. This includes Scope 1 emissions of about 89,118,000 kg CO2e, Scope 2 emissions of approximately 24,888,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 4,160,471,000 kg CO2e. The combined Scope 1 and 2 emissions amounted to about 114,006,000 kg CO2e. Daiichi Sankyo has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions by FY2050. This long-term goal encompasses all scopes of emissions. In the near term, the company has committed to reducing absolute Scope 1 and 2 emissions by 63% by FY2030, using FY2015 as the baseline year. Additionally, they plan to increase their sourcing of renewable electricity from 4% in FY2015 to 100% by FY2030. Furthermore, they aim for 70.6% of their suppliers, based on emissions, to have science-based targets by FY2025. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Daiichi Sankyo's commitment to addressing climate change through responsible corporate practices. The company is actively working towards these goals while also focusing on energy efficiency and carbon reduction in its operations.
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 182,519,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 290,715,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 5,704,000 | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Daiichi Sankyo's Scope 3 emissions, which decreased by 6% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 85% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Daiichi Sankyo has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Daiichi Sankyo's sustainability data and climate commitments